The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for apadamtase alfa (Takeda Pharmaceuticals Aust Pty Ltd)
Active ingredients
apadamtase alfa
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
powder for injection with solvent
Indication
Prophylaxis and treatment of thrombotic thrombocytopenic purpura
Therapeutic area
Haematology